Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
186.00
-0.86 (-0.46%)
Official Closing Price
Updated: 7:00 PM EST, Nov 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Johnson & Johnson
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
99
100
Next >
Johnson & Johnson Q4 Earnings And Revenues Top Estimates
January 22, 2025
Johnson & Johnson came out with quarterly earnings of $2.04 per share.
Via
Talk Markets
Topics
Stocks / Equities
J&J Stock Dips As 2025 Sales Guidance Misses Estimate, But Retail Mood Resilient
January 22, 2025
During the earnings call, J&J highlighted several growth drivers, including its positioning for 5%-7% annual growth through 2030 and plans to increase its dividend annually.
Via
Stocktwits
Topics
Earnings
Johnson & Johnson Tops Q4 EPS Forecasts
January 22, 2025
Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.
Via
The Motley Fool
Topics
Intellectual Property
Johnson & Johnson Q4 Earnings: Cancer Drugs Performance Drives Revenue Beat, Issues Strong FY25 Outlook
January 22, 2025
Johnson & Johnson's Q4 sales hit $22.52 billion, with strong growth in MedTech and oncology. 2025 guidance shows promising EPS and revenue forecasts.
Via
Benzinga
Johnson & Johnson Earnings Narrowly Top But Dow Giant's Sales Guidance Light
January 22, 2025
The Dow Jones stock fell slightly early Wednesday.
Via
Investor's Business Daily
Topics
Stocks
Johnson & Johnson Reports Q4 and Full-Year 2024 Results
January 22, 2025
From
Johnson & Johnson
Via
Business Wire
US Stocks Likely To Open Higher As President Trump Announces $500 Billion AI Project: Oracle, Netflix, Nvidia Among Top Stocks To Watch
January 22, 2025
U.S. stocks could open on a positive note on Wednesday, continuing to rally after Donald Trump's inauguration as the 47th President of the U.S. on Monday.
Via
Benzinga
Topics
Artificial Intelligence
Government
Dow Jumps Over 500 Points As Trump Takes Office: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
January 22, 2025
The CNN Business Fear & Greed Index measures market sentiment, with higher fear putting pressure on stocks.
Via
Benzinga
Topics
Government
Stocks
Earnings Scheduled For January 22, 2025
January 22, 2025
Via
Benzinga
Netflix, Procter & Gamble And 3 Stocks To Watch Heading Into Wednesday
January 22, 2025
Via
Benzinga
Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
January 22, 2025
Via
Benzinga
Big Trading Day Ends With Q4 Earnings Beats: NFLX, UAL, COF
January 21, 2025
Markets had a strong session on the first full day of President Trump’s second administration. Indexes have rocketed up from 2025 lows hit a week to a week and a half ago.
Via
Talk Markets
Topics
Government
Stocks / Equities
Johnson & Johnson Q4 Earnings Loom As FDA Approves Depression Drug: Will Long-Term Weakness Reverse?
January 21, 2025
JNJ stock reporting earnings, expecting $2 EPS and $22.44B revenue, approval for Spravato, mixed chart signals, $167.71 price target - 13% upside
Via
Benzinga
Johnson & Johnson Q4 Preview: Can Earnings Bring Health Care 'Back To Life'?
January 21, 2025
Johnson & Johnson is one of several Dow Jones Industrial Average stocks reporting financial results this week. A look at the key items and numbers to watch.
Via
Benzinga
Topics
Stocks
FDA Approves Johnson & Johnson's Treatment As First Monotherapy For Treatment-Resistant Depression
January 21, 2025
FDA approves Johnson & Johnson's Spravato nasal spray as a monotherapy for major depressive disorder, showing superior efficacy in clinical trials.
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), H&E Equipment Services, Inc. (Nasdaq - HEES), Shutterstock, Inc. (NYSE - SSTK)
January 21, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
January 21, 2025
Via
The Motley Fool
Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?
January 21, 2025
Via
The Motley Fool
Topics
Stocks
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever
January 21, 2025
Via
The Motley Fool
Healthcare And Biotech Stocks Lag The Market Again
January 20, 2025
Biotech stocks got little help from the JPM Conference despite some recovery to the general market.
Via
Talk Markets
Topics
Stocks / Equities
8 Health Care Stocks Whale Activity In Today's Session
January 20, 2025
Via
Benzinga
MicroStrategy, SoFi Technologies And Carvana Are Among Top Large-Cap Gainers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
January 19, 2025
These 11 large-cap stocks saw significant growth last week, with notable news from companies such as Johnson & Johnson, MicroStrategy, and United Rentals.
Via
Benzinga
MarketBeat Week in Review – 01/13 - 01/17
January 18, 2025
The sell-off in stocks reversed abruptly this week on better-than-expected inflation readings; investors will want to see strong earnings to support the rally
Via
MarketBeat
Topics
Economy
Energy
3 Super-Safe Dividend Stocks to Buy for 2025 and Beyond
January 18, 2025
Via
The Motley Fool
Wall Street's Greatest Dividend Stock -- a Small-Cap Company 99% of Investors Have Never Heard of -- Is the Cheapest It's Been in Over a Decade
January 18, 2025
This magnificent company has been paying a continuous dividend to its shareholders since 1816.
Via
The Motley Fool
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
January 17, 2025
Deal opportunities abound: KKR & Co.'s stake in Maya; DuPont's electronics business; Ingevity's North Charleston site; and S&W Seed Company.
Via
Benzinga
Topics
Government
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review
January 17, 2025
Many stocks flashed buy signals as the major indexes rose to or above key levels.
Via
Investor's Business Daily
Topics
Economy
Is Johnson & Johnson Stock Set to Reward Long-Term Holders?
January 17, 2025
JNJ stock is up 1.8% after announcing its $14.6 billion acquisition of Intra-Cellular Therapeutics, which may make this undervalued dividend king attractive
Via
MarketBeat
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
January 17, 2025
These companies lead their respective markets, making them must-haves for buy-and-hold dividend investors.
Via
The Motley Fool
10 One Decision Stocks To Buy Now
January 15, 2025
The following 10 one decision stocks have increased their dividends for over 25 years, making them Dividend Aristocrats.
Via
Talk Markets
Topics
Stocks / Equities
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today